INNT
TOTAL INVALIDATION PROCESSED BY THE IB
08/08/2025
Back to search
Official data from USPTO
PHARMAPAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMAPAN
ST13
US500000079212134Class
35, 42, 45
Filing
79212134
Registration
5388978
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/09/2025
Trademark type
Word
Nice classes
35, 42, 45
Filing date
04/07/2017
Registration date
01/30/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2024
Last transaction
08/09/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
BECHHOFER, YOCHEVED
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PANTEC AG
Representatives
John Alumit ALUMIT IP
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
wholesale distributorship services in the field of pharmaceutical products and cuttingwrapping and packaging machinery; trademark creation services for others
Class 42
scientific servicesscientific research and development; technological servicesproviding technology information in the field of pharmaceutical products and cuttingwrapping and packaging machinery ; technological planning and consultation in the field of pharmaceutical products and cuttingwrapping and packaging machinery as well as research and design relating thereto; industrial analysis and research servicesconsulting in the field of industrial engineeringresearch in the field of pharmaceutical products and cuttingwrapping and packaging machineryanalysis in the field of industrial processes; design and development of computers and software; scientific research and development of pharmaceuticals and machinery for the pharmaceutical industry; consulting services in the field of pharmaceutical research; provision of information relating to medical and scientific research in the field of pharmaceutical products; consulting services in the field of pharmaceutical technology development; consulting services in the field of pharmaceutical research and development; advice relating to technological processes and optimization thereof in the field of pharmaceutical research and pharmaceutical machinery; consulting services in the field of technological research in the field of pharmaceuticals; consultancy in connection with pharmaceutical research and pharmaceutical machinery technology; designdevelopmentmaintenance and updating of process control software as well as advice relating thereto; research and development services concerning new products; design and development of new technologies for others in the field of pharmaceuticals; analysis and evaluation of product development; product development; pharmaceutical machinery design services; industrial design; packaging design services; new product design services; technical design of industrial installations for pharmaceutical development and pharmaceutical packaging
Class 45
Legal services; consulting services relating to intellectual property licensing; legal services relating to the managementcontrol and granting of license rights; licensing of pharmaceutical research and development; licensing of industrial property rights and copyrights; licensing services relating to music publishing; legal administration of licenses; management and exploitation of copyright and industrial property rights by licensing copyrights and industrial property rights to third parties; licensing services relating to the manufacture of goods; granting of licenses to third parties for industrial property right and copyright use; legal consulting services relating to industrial design protection
Publications
History of USPTO decisions and trademark events.
35 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/21/2025
INPC
INVALIDATION PROCESSED
07/21/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/16/2025
C71T
CANCELLED SECTION 71
08/16/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/30/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/15/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/03/2018
FIMP
FINAL DISPOSITION PROCESSED
05/03/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/30/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
01/30/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/14/2017
PUBO
PUBLISHED FOR OPPOSITION
11/14/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/25/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/10/2017
ALIE
ASSIGNED TO LIE
10/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/20/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/15/2017
GNFR
FINAL REFUSAL E-MAILED
09/15/2017
CNFR
FINAL REFUSAL WRITTEN
09/15/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/24/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/24/2017
RFNP
REFUSAL PROCESSED BY IB
08/18/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/28/2017
RFRR
REFUSAL PROCESSED BY MPU
07/28/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/26/2017
CNRT
NON-FINAL ACTION WRITTEN
07/25/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/21/2017
DOCK
ASSIGNED TO EXAMINER
07/17/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/13/2017
Continuous trademark protection
Get notified about every new filing that threatens PHARMAPAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.